{
    "2019-10-21": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock sinks",
                        "market gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-15",
                "original_text": "What's in Store for Healthcare ETFs in Q3 Earnings?",
                "features": {
                    "keywords": [
                        "healthcare",
                        "ETFs",
                        "Q3 earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-21",
                "original_text": "What to expect from the landmark opioid trial",
                "features": {
                    "keywords": [
                        "opioid",
                        "trial",
                        "landmark"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-11-04",
                "original_text": "Opko and Pfizer announce positive results in late-stage trial of human growth hormone treatment",
                "features": {
                    "keywords": [
                        "Opko",
                        "Pfizer",
                        "positive results",
                        "late-stage trial",
                        "human growth hormone"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-04",
                "original_text": "OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency",
                "features": {
                    "keywords": [
                        "OPKO",
                        "Pfizer",
                        "Phase 3",
                        "Somatrogon",
                        "positive results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-23",
                "original_text": "TIMELINE-Popular heartburn medicine Zantac pulled off store shelves",
                "features": {
                    "keywords": [
                        "Zantac",
                        "pulled off shelves",
                        "heartburn medicine"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}